[go: up one dir, main page]

NO20011537L - Chemokin-reseptorpeptidvaksiner for behandling og forebygging av diabetes - Google Patents

Chemokin-reseptorpeptidvaksiner for behandling og forebygging av diabetes

Info

Publication number
NO20011537L
NO20011537L NO20011537A NO20011537A NO20011537L NO 20011537 L NO20011537 L NO 20011537L NO 20011537 A NO20011537 A NO 20011537A NO 20011537 A NO20011537 A NO 20011537A NO 20011537 L NO20011537 L NO 20011537L
Authority
NO
Norway
Prior art keywords
prevention
treatment
chemokine receptor
diabetes
peptide vaccines
Prior art date
Application number
NO20011537A
Other languages
English (en)
Other versions
NO20011537D0 (no
Inventor
Maureen Howard
Shrikant Deshpande
Walter Ferlin
Subhashini Arimilli
Original Assignee
Corixa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Corixa Corp filed Critical Corixa Corp
Publication of NO20011537D0 publication Critical patent/NO20011537D0/no
Publication of NO20011537L publication Critical patent/NO20011537L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7158—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for chemokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Foreliggende oppfinnelse tilveiebringer immunogene oligopeptider avledet fra chemokin-reseptorproteinet for anvendelse i sammensetninger og fremgangsmåter for behandling, og forebygging av inflammatoriske responser.
NO20011537A 1998-09-30 2001-03-26 Chemokin-reseptorpeptidvaksiner for behandling og forebygging av diabetes NO20011537L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/164,186 US6171590B1 (en) 1998-09-30 1998-09-30 Chemokine receptor peptide for inducing an immune response
PCT/US1999/022992 WO2000018431A1 (en) 1998-09-30 1999-09-30 Chemokine receptor peptide vaccines for treatment and prevention of diabetes

Publications (2)

Publication Number Publication Date
NO20011537D0 NO20011537D0 (no) 2001-03-26
NO20011537L true NO20011537L (no) 2001-05-28

Family

ID=22593363

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20011537A NO20011537L (no) 1998-09-30 2001-03-26 Chemokin-reseptorpeptidvaksiner for behandling og forebygging av diabetes

Country Status (10)

Country Link
US (2) US6171590B1 (no)
EP (1) EP1117429A4 (no)
JP (1) JP2002525338A (no)
KR (1) KR20010082217A (no)
CN (1) CN1328470A (no)
AU (1) AU6285399A (no)
CA (1) CA2345978A1 (no)
IL (1) IL142283A0 (no)
NO (1) NO20011537L (no)
WO (1) WO2000018431A1 (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7888466B2 (en) 1996-01-11 2011-02-15 Human Genome Sciences, Inc. Human G-protein chemokine receptor HSATU68
JP2000506365A (ja) * 1996-01-11 2000-05-30 ヒューマン ジノーム サイエンシーズ，インコーポレイテッド ヒトｇタンパク質ケモカインレセプターｈｓａｔｕ６８
US6140064A (en) * 1996-09-10 2000-10-31 Theodor-Kocher Institute Method of detecting or identifying ligands, inhibitors or promoters of CXC chemokine receptor 3
AU2001249546A1 (en) * 2000-03-27 2001-10-08 Corixa Corporation Methods for treating disease with antibodies to cxcr3
FR2817260A1 (fr) * 2000-11-29 2002-05-31 Centre Nat Rech Scient Peptides ayant des proprietes anti-inflammatoires, leurs utilisations et les compositions les contenant
WO2004012751A1 (ja) * 2002-08-02 2004-02-12 Sumitomo Pharmaceuticals Company, Limited 細菌細胞壁骨格成分製剤
CA2558813A1 (en) * 2004-03-09 2005-09-15 Kyoto University Pharmaceutical composition comprising cxcr3 inhibitor
WO2005102369A1 (ja) * 2004-04-22 2005-11-03 Dainippon Sumitomo Pharma Co., Ltd. 細菌細胞壁骨格成分を含有する製剤
EP2004675A1 (en) * 2006-03-16 2008-12-24 Protagonists Ltd. Combination of cytokine and cytokine receptor for altering immune system functioning
CN100450552C (zh) * 2006-05-26 2009-01-14 中国医学科学院医学生物学研究所 Ⅰ型糖尿病疫苗及其构建方法
US12072338B2 (en) * 2007-03-18 2024-08-27 Protagonists Ltd. Pharmaceutical peptides for the treatment of inflammatory diseases
ES2456963T3 (es) 2007-06-04 2014-04-24 Rappaport Family Institute For Research In The Medical Sciences Agentes para el tratamiento de enfermedades inflamatorias y métodos para usar los mismos
WO2010103517A1 (en) * 2009-03-12 2010-09-16 Rappaport Family Institute For Research In The Medical Sciences Soluble compositions for the treatment of cxcr3-ligand associated diseases
WO2014186842A1 (en) * 2013-05-22 2014-11-27 Monash University Antibodies and uses thereof
TW201718851A (zh) * 2015-09-18 2017-06-01 通用醫院公司 具有抗化學排斥(anti-fugetactic)性質之經修飾自然殺手細胞及其用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6537764B1 (en) * 1995-01-19 2003-03-25 Children's Medical Center Corporation Method of identifying inhibitors of C—C chemokine receptor 3
AU4898496A (en) 1996-01-11 1997-08-01 Human Genome Sciences, Inc. Human g-protein chemokine receptor hsatu68
JP4502408B2 (ja) 1996-09-10 2010-07-14 テオドーア−コッヒャー インスティトゥーテ Ｃｘｃｒ３ケモカイン受容体、抗体、核酸および使用方法
US6528625B1 (en) * 1996-10-28 2003-03-04 Millennium Pharmaceuticals, Inc. Anti-CCR5 antibodies and kits comprising same
SE9801098D0 (sv) 1998-03-30 1998-03-30 Astra Pharma Prod Receptors

Also Published As

Publication number Publication date
IL142283A0 (en) 2002-03-10
CN1328470A (zh) 2001-12-26
CA2345978A1 (en) 2000-04-06
EP1117429A4 (en) 2002-11-20
WO2000018431A1 (en) 2000-04-06
AU6285399A (en) 2000-04-17
JP2002525338A (ja) 2002-08-13
KR20010082217A (ko) 2001-08-29
EP1117429A1 (en) 2001-07-25
NO20011537D0 (no) 2001-03-26
US6171590B1 (en) 2001-01-09
US20010006942A1 (en) 2001-07-05

Similar Documents

Publication Publication Date Title
WO1998033509A3 (en) Useful properties of human lactoferrin and variants thereof
MXPA00010722A (es) Antigenos de neisseria meningitidis y composiciones que los contienen.
NO20011537L (no) Chemokin-reseptorpeptidvaksiner for behandling og forebygging av diabetes
DK1353689T3 (da) Immuniseringspræparater og anvendelse deraf
EP1231218A3 (en) An appetite-suppressing peptide, its compositions and use
DK0883687T3 (da) C-C CKR-5, CC-chemokinreceptor, derivater deraf og anvendelse deraf
DK1187591T3 (da) IBD-associerede mikrobielle antigener og fremgangsmåder til at anvende samme
YU9404A (sh) Multimerna, usmerena kontrastna sredstva na bazi peptida
DK1185691T3 (da) Genomiske neisseriasekvenser og fremgangmåder til anvendelse deraf
DK1203817T3 (da) Forbindelser og fremgangsmåder til immunterapi og diagnose af tuberkulose
DK0760848T3 (da) Lactobacillusstammer af menneskelig oprindelse, deres sammensætninger og anvendelse deraf
DK1210430T3 (da) MUC-1-afledte peptider
DK0960127T3 (da) Isoleret dimert fibroblastaktiverende protein-alfa og anvendelser deraf
ATE398630T1 (de) Zyklische conotoxin-peptide
ATE551069T1 (de) Mucin-fusionspolypeptid-vakzine, zusammensetzungen und ihre verwendung
DK1276763T3 (da) Anti-fryseproteiner, deres fremstilling og anvendelse
NO20060093L (no) Plate glykoprotein IB alfa-variant fusjonspolypeptider og fremgangsmater for anvendelse derav
DK0781344T3 (da) Hidtil ukendt implantat og hidtil ukendt vektor til behandling af erhvervede sygdomme
EP1978994A4 (en) BMP-7 VARIANTS COMPOSITIONS, METHODS AND USES
NO961423D0 (no) Oligopeptider avledet fra C-reaktive proteinfragmenter
DK0863981T3 (da) Detektering, forebyggelse og behandling af papillomatous digital dermatitis
DK1159426T3 (da) Kloning og udtryk af Haemophilus somnus transferrin-bindende proteiner
WO2003087841A3 (en) An ephrin-b receptor protein involved in carcinoma
WO2001092468A3 (en) Novel compositions for the expression of the human peptide histidine transporter 1 and methods of use thereof
DE60005526D1 (de) Verwendung von 2-amino-4-(4-fluoronaphth-1-yl)-6-isopropylpyrimidine zur behandlung von erkrankungen des magen-darm-traktes

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application